We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.1%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
-$227M
(-4.4%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-2.42%
Top 10 Holdings %
Top 10 Hldgs %
24.91%
Holding
802
New
109
Increased
252
Reduced
267
Closed
54
Avg Time Held
1.6
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ventas
VTR
|
+$29.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$28.3M |
| 3 |
Ecolab
ECL
|
+$25.4M |
| 4 |
Merck
MRK
|
+$24.7M |
| 5 |
Edwards Lifesciences
EW
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ServiceNow
NOW
|
+$44M |
| 2 |
SBA Communications
SBAC
|
+$43.3M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$42M |
| 4 |
TD Ameritrade Holding Corp
AMTD
|
+$40.5M |
| 5 |
Gilead Sciences
GILD
|
+$39.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.75% |
| 2 | Consumer Discretionary | 15.42% |
| 3 | Technology | 15.27% |
| 4 | Financials | 12.99% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
STAR.PRE
526
DELISTED
iStar Inc.
STAR.PRE
| $202K | ﹤0.01% |
+9,114
| New | +$190K |
2016 Q1
0 quarters
|
|
527
Corning
GLW
$119B
| $201K | ﹤0.01% |
+9,642
| New | +$179K |
2016 Q1
0 quarters
|
|
528
Alcoa
AA
$10.7B
| $198K | ﹤0.01% |
8,614
+856
| +11% | +$17.4K |
2013 Q2
11 quarters
|
|
529
Hewlett Packard
HPE
$77.8B
| $189K | ﹤0.01% |
+18,350
| New | +$154K |
2016 Q1
0 quarters
|
|
|
TXTR
530
DELISTED
TEXTURA CORPORATION COM
TXTR
| $188K | ﹤0.01% |
+10,075
| New | +$169K |
2016 Q1
0 quarters
|
|
|
XPLR
531
DELISTED
Xplore Technologies Corp.
XPLR
| $187K | ﹤0.01% |
53,541
| – | – |
2015 Q4
1 quarter
|
|
|
GNMK
532
DELISTED
GenMark Diagnostics, Inc
GNMK
| $174K | ﹤0.01% |
33,015
-1,512
| -4% | -$8.42K |
2014 Q4
5 quarters
|
|
533
iShares Silver Trust
SLV
$27.9B
| $171K | ﹤0.01% |
+11,663
| New | +$166K |
2016 Q1
0 quarters
|
|
|
CSII
534
DELISTED
Cardiovascular Systems, Inc.
CSII
| $159K | ﹤0.01% |
15,330
| – | – |
2014 Q3
6 quarters
|
|
535
Oxford Lane Capital
OXLC
$820M
| $153K | ﹤0.01% |
3,630
| – | – |
2013 Q3
10 quarters
|
|
536
Radian Group
RDN
$4.45B
| $151K | ﹤0.01% |
12,206
| – | – |
2015 Q4
1 quarter
|
|
537
HP
HPQ
$27.8B
| $141K | ﹤0.01% |
11,464
+1,257
| +12% | +$13.4K |
2013 Q4
9 quarters
|
|
538
Rithm Capital
RITM
$4.86B
| $141K | ﹤0.01% |
12,136
| – | – |
2015 Q1
4 quarters
|
|
539
United States Oil Fund
USO
$2.02B
| $132K | ﹤0.01% |
1,704
+172
| +11% | +$12.8K |
2015 Q3
2 quarters
|
|
540
First Majestic Silver
AG
$7.93B
| $126K | ﹤0.01% |
19,383
| – | – |
2015 Q4
1 quarter
|
|
541
Wendy's
WEN
$1.28B
| $109K | ﹤0.01% |
10,000
| – | – |
2014 Q3
6 quarters
|
|
|
SCU
542
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $105K | ﹤0.01% |
2,410
-741
| -24% | -$34.9K |
2014 Q2
7 quarters
|
|
|
IMMU
543
DELISTED
Immunomedics Inc
IMMU
| $104K | ﹤0.01% |
41,435
-120
| -0.3% | -$270 |
2015 Q4
1 quarter
|
|
544
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.69B
| $100K | ﹤0.01% |
+13,226
| New | +$94.9K |
2016 Q1
0 quarters
|
|
|
ELI
545
DELISTED
ELITE PHARMACEUTICAL
ELI
| $91K | ﹤0.01% |
293,180
| – | – |
2013 Q2
11 quarters
|
|
|
FCFP
546
DELISTED
FIRST COMMUNITY FINANCIAL PARTNERS INC.
FCFP
| $87K | ﹤0.01% |
10,000
| – | – |
2015 Q3
2 quarters
|
|
547
SiriusXM
SIRI
$9.15B
| $76K | ﹤0.01% |
1,920
-1,067
| -36% | -$39.9K |
2013 Q2
11 quarters
|
|
548
Ultra Clean Holdings
UCTT
$2.53B
| $73K | ﹤0.01% |
13,601
| – | – |
2015 Q3
2 quarters
|
|
549
Sabesp
SBS
$22B
| $67K | ﹤0.01% |
+52,571
| New | +$55.6K |
2016 Q1
0 quarters
|
|
|
FTR
550
DELISTED
Frontier Communications Corp.
FTR
| $64K | ﹤0.01% |
759
+71
| +10% | +$5.16K |
2014 Q1
8 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Geneva Advisors held 802 positions worth $4.97B, down 4.4% from $5.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Geneva Advisors's Q1 2016 filing shows 109 new, 252 increased, 267 reduced and 54 closed positions. Its largest new stake was Ventas: 517,036 shares worth $32.6M. The largest sale was ServiceNow, an estimated $44M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
- Geneva Advisors's largest Q1 2016 buy was Ventas: 517,036 shares worth $32.6M.
- Geneva Advisors added most to Bristol-Myers Squibb in Q1 2016, an estimated $28.3M increase.
- Geneva Advisors's biggest Q1 2016 reduction was SBA Communications, cutting an estimated $43.3M.
- Geneva Advisors fully exited ServiceNow in Q1 2016, selling an estimated $44M.
- Geneva Advisors's ten largest holdings make up 25% of its $4.97B portfolio in Q1 2016.
- Geneva Advisors opened 109 new positions and closed 54 in Q1 2016.
- Geneva Advisors's portfolio value fell 4.4% quarter-over-quarter to $4.97B.
Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.